Blood Cancer Talks

In this episode, we discuss the management of newly diagnosed DLBCL with Dr. Pallawi Torka. We also have a few bonus ASH22 updates on DLBCL. Links to articles and abstracts discussed in the episode are as follows: 

1. A comprehensive review article on DLBCL:
2. RCT testing CHOP vs Three Intensive Regimens in DLBCL: 
3. RCT testing R-CHOP vs CHOP in DLBCL in older adults: 
4. RCT testing R-CHOP vs CHOP in young (MINT): 
5. PHOENIX trial: R-CHOP +/- Ibrutinib:
6. R-CHOP +/- Lenalidomide (ECOG-ACRIN E1412): 
7. R-CHOP vs Pola-R-CHP (POLARIX Trial):
8. Comparison of 3 IPI scores in DLBCL:
9. RCT testing R-CHOP vs Dose-Adjusted R-EPOCH (CALGB 50303):
10. Timing of CNS Prophylaxis in DLBCL:
11. RCT testing R-CHOP vs R-CHOP + Bortezomib (REMoDL-B):
12. Interim PET in DLBCL?
13. RCTs in Limited Stage DLBCL:
CHOP x 8 vs CHOP x 3 + XRT (S8736):
CHOP x 4 + Rituximab x 6 vs R-CHOP x 6 (FLYER):
PET-adapted therapy with R-CHOP (S1001):
14.   ASH 2022 updates:
REMoDL-B update:
Glofitamab update:
Epcoritamab update:

What is Blood Cancer Talks?

This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk